Michel Vounatsos

Insider Reports History

Entity
Individual
Location
940 Winter Street, Revvity, Waltham, MA
Signature
/s/ Bruce Blefeld, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michel Vounatsos:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIOGEN INC. Chief Executive Officer, Director Common Stock 67.3K $16.7M $248.00 Feb 18, 2022 Direct
BIOGEN INC. Chief Executive Officer, Director Restricted Stock Unit 30.2K $7.23M $239.29 Feb 18, 2022 Direct
REVVITY, INC. Director Common Stock 9.29K $961K $103.49 May 1, 2024 Direct
Zai Lab Ltd Director American Depositary Shares 39.6K $845K $21.33 Jun 18, 2024 Direct

Insider Reports Filed by Michel Vounatsos

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZLAB Zai Lab Ltd Jun 18, 2024 1 $0 4 Jun 20, 2024 Director
RVTY REVVITY, INC. May 1, 2024 2 $0 4 May 2, 2024 Director
RVTY REVVITY, INC. May 15, 2023 2 $0 4 May 17, 2023 Director
ZLAB Zai Lab Ltd Mar 3, 2023 1 $0 4 Mar 7, 2023 Director
ZLAB Zai Lab Ltd Jan 7, 2023 0 $0 3 Jan 13, 2023 Director
RVTY PERKINELMER INC May 6, 2022 2 $0 4 May 9, 2022 Director
BIIB BIOGEN INC. Feb 18, 2022 4 -$576K 4 Feb 23, 2022 Chief Executive Officer, Director
BIIB BIOGEN INC. Feb 12, 2022 9 -$1.84M 4 Feb 15, 2022 Chief Executive Officer, Director
BIIB BIOGEN INC. Feb 10, 2022 1 $0 4 Feb 14, 2022 Chief Executive Officer, Director
BIIB BIOGEN INC. Jan 19, 2022 1 $0 4 Jan 21, 2022 Chief Executive Officer, Director
RVTY PERKINELMER INC May 7, 2021 2 $0 4 May 10, 2021 Director